Facebook Linkedin RSS Twitter Youtube
Home 2024

Myelodysplastic syndrome

Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice
Cancer

Uncovering RNA Splicing’s Cell-Specific Impact on Clonal Blood Disorders with GoT-Splice

Stem Cell Groups Found That Drive Myelodysplastic Syndromes
Cancer

Stem Cell Groups Found That Drive Myelodysplastic Syndromes

Researchers Uncover Underlying Mechanisms of Rare Blood Cancer
Cancer

Researchers Uncover Underlying Mechanisms of Rare Blood Cancer

Bluebird Bio Finds Lentiviral Vector “Unlikely” Cause of Clinical Trial’s Adverse Events
Genome Editing

Bluebird Bio Finds Lentiviral Vector “Unlikely” Cause of Clinical Trial’s Adverse Events

J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration
Cancer

J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration

The Stem Cell: Life’s Goblet or Poisoned Chalice?
Featured

The Stem Cell: Life’s Goblet or Poisoned Chalice?

Syros Pursues Combination Development for Lead Candidate after Phase II Miss
Cancer

Syros Pursues Combination Development for Lead Candidate after Phase II Miss

Sunesis Withdraws European MAA for AML Drug Vosaroxin
Cancer

Sunesis Withdraws European MAA for AML Drug Vosaroxin

FDA Lifts Clinical Hold on Seattle Genetics Trials
Cancer

FDA Lifts Clinical Hold on Seattle Genetics Trials

Helsinn Teams Up with MEI Pharma to Develop AML Compound Pracinostat
Cancer

Helsinn Teams Up with MEI Pharma to Develop AML Compound Pracinostat

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.